Delivery Order SPE2DB20D3304-SPE2DB24FW6V9
Award Date
7/28/24
Potential Completion Date
7/29/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $1,351.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a specialty medication, with a completion date of May 10, 2023. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of MESALAMINE DR 400 MG CAPSULE 180S. The $1,560.29 firm fixed-price Delivery Order does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.02, is a delivery order for 4567340127 - MESALAMINE DR 400 MG CAPSULE 180S. The contract has an ultimate completion date of February 24, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,589.52 Firm Fixed Price Delivery Order covers the procurement of 4566901592 - MESALAMINE DR 400 MG CAPSULE 180S, with a period of performance through January 14, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUM77, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,567,223,297 units of MESALAMINE DR 400 MG CAPSULE 180S, with a ceiling value of $5,218.80. The contract type is a Delivery Order with a Firm Fixed Price pricing type. The period of performance runs through February 11, 2025. This contract award was not designated with any set-aside...
This federal contract award, valued at $2,774.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MESALAMINE DR 400 MG CAPSULE 180S, a pharmaceutical product, under a Firm Fixed Price contract type. The contract does not have a set-aside designation, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $4,040.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a medical product, and is a Firm Fixed Price Delivery Order with an ultimate completion date of March 14, 2025. The contract was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.80 firm fixed-price delivery order covers the procurement of 4,567,343,614 units of Mesalamine DR 400 mg capsules. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D3016|SPE2DB24FAVF2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,229.45 Firm Fixed Price Delivery Order is for the supply of MESALAMINE DR 400 MG CAPSULE 180S, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of May 13, 2024. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.32 Firm Fixed Price delivery order is for the supply of 4566550847 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...